Kymera Therapeutics Inc (KYMR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 81,051 | 52,386 | 50,152 | 68,395 | 155,658 |
| Marketable Securities | 276,774 | 315,188 | 346,725 | 338,771 | 326,250 |
| Other current assets | 3,778 | 4,122 | 3,320 | 2,537 | 2,882 |
| TOTAL | $375,694 | $385,402 | $411,550 | $419,416 | $494,022 |
| Non-Current Assets | |||||
| PPE Net | 36,145 | 27,494 | 17,432 | 13,334 | 12,569 |
| Investments And Advances | 76,988 | 104,759 | 119,017 | 152,328 | 113,701 |
| Other Non-Current Assets | 63,551 | 64,290 | 65,906 | 18,056 | 18,180 |
| TOTAL | $176,684 | $196,543 | $202,355 | $183,718 | $144,450 |
| Total Assets | $552,378 | $581,945 | $613,905 | $603,134 | $638,472 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,978 | 3,745 | 6,483 | 4,335 | 6,327 |
| Accrued Expenses | 26,383 | 22,490 | 18,502 | 27,502 | 24,692 |
| Other current liabilities | 858 | 268 | 807 | 303 | 710 |
| TOTAL | $63,166 | $54,602 | $61,933 | $71,343 | $91,124 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 27,352 | 24,302 | 32,248 | 35,260 | 55,776 |
| Other Non-Current Liabilities | 76,613 | 70,732 | 64,112 | 12,394 | 12,687 |
| TOTAL | $93,677 | $91,915 | $89,967 | $41,640 | $34,463 |
| Total Liabilities | $156,843 | $146,517 | $151,900 | $112,983 | $125,587 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 55,487 | 55,412 | 55,308 | 55,184 | 54,865 |
| Common Shares | 6 | 6 | 6 | 6 | 6 |
| Retained earnings | -516,384 | -463,517 | -424,718 | -383,790 | -348,925 |
| Other shareholders' equity | -2,450 | -3,635 | -3,038 | -4,949 | -5,913 |
| TOTAL | $395,535 | $435,428 | $462,005 | $490,151 | $512,885 |
| Total Liabilities And Equity | $552,378 | $581,945 | $613,905 | $603,134 | $638,472 |